Monday, October 2, 2017
Physicians are on the front lines when it comes to confronting the stark realities of the opioid epidemic. Not only are they the ones holding the prescription pads, but they’re also in the emergency rooms when drug overdose patients are brought in—these days at an alarming rate.
That’s why a number of physicians are hoping to tackle the crisis head-on, drawing on their clinical and pharmacological expertise to test new compounds or develop new products for keeping drugs out of the hands of people with an addiction.
Bridge Therapeutics, based in Birmingham, Ala., is one of a number of physician-led companies working on solutions to the opioid epidemic. For Sullivan, the answer is an already-approved drug called buprenorphine, which is used to treat drug addiction.